526.97USD+1.88%Mkt Cap: 12.13B USDP/E: —Last update: 2026-05-26
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directe…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap12.13B USD
Enterprise Value11.38B USD
Revenue (TTM)1.13B USD
Gross Profit902.25M USD
Net Income (TTM)-288.28M USD
Revenue/Share49.95 USD
Last Price526.97 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees915
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS5588681057
Valuation
P/E (Trailing)—
P/E (Forward)41.49
PEG—
EV/EBITDA-36.46
EV/Revenue10.04
P/S10.46
P/B21.78
EPS (TTM)-13.51
EPS (Forward)12.38
52W Range
265.0075% of range615.00
52W High615.00 USD
52W Low265.00 USD
Profitability
Gross Margin94.14%
Oper. Margin-29.78%
EBITDA Margin-27.55%
Profit Margin-30.08%
ROE-47.83%
ROA-22.89%
Growth
Revenue Growth126.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-189.55M USD
CapEx (TTM)3.47M USD
FCF Margin-13.81%
FCF Yield-1.29%
Net Debt-465.46M USD
Net Debt/EBITDA1.49
Balance Sheet
Debt/Equity0.58
Current Ratio3.50
Quick Ratio2.96
Book Value/Sh23.59 USD
Cash/Share35.25 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 25, 2016
Splits
Last Split1:35
Split DateJul 25, 2016
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)674.36 USD
Target Range550.00 USD – 964.00 USD
# Analysts14
Ownership
Shares Out.23.06M
Float12.90M
Insiders5.70%
Institutions106.07%
Short Interest
Short Ratio13.3d
Short % Float19.66%
Short % Out.16.72%
Shares Short3.85M
Short (prev mo.)3.91M
Technical
SMA 50505.76 (+4.2%)
SMA 200483.61 (+9.0%)
Beta-1.04
S&P 52W Chg28.31%
Avg Vol (30d)269.65K
Avg Vol (10d)301.94K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—